201 related articles for article (PubMed ID: 23757317)
1. Oncocytic carcinoid tumor of the lung with intense F-18 fluorodeoxyglucose (FDG) uptake in positron emission tomography-computed tomography (PET/CT).
Tanabe Y; Sugawara Y; Nishimura R; Hosokawa K; Kajihara M; Shimizu T; Takahashi T; Sakai S; Sawada S; Yamashita M; Ohtani H
Ann Nucl Med; 2013 Oct; 27(8):781-5. PubMed ID: 23757317
[TBL] [Abstract][Full Text] [Related]
2. A case of pulmonary typical carcinoid with an extensive oncocytic component showing intense uptake of FDG.
Kadowaki T; Yano S; Araki K; Tokushima T; Morioka N
Thorax; 2011 Apr; 66(4):361-2. PubMed ID: 21075777
[No Abstract] [Full Text] [Related]
3. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
[TBL] [Abstract][Full Text] [Related]
4. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyglucose positron emission tomography in pulmonary carcinoid tumors.
Gasparri R; Rezende GC; Fazio N; Maisonneuve P; Brambilla D; Travaini LL; Paganelli G; Petrella F; Galetta D; Spaggiari L
Q J Nucl Med Mol Imaging; 2015 Dec; 59(4):446-54. PubMed ID: 26416036
[TBL] [Abstract][Full Text] [Related]
6. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
7. Bronchogenic carcinoid tumours that are 18F-fluorodeoxyglucose avid on positron emission tomography.
Hunt BM; Horton MP; Vallières E
Eur J Cardiothorac Surg; 2014 Mar; 45(3):527-30. PubMed ID: 24047710
[TBL] [Abstract][Full Text] [Related]
8. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
Shin V; Bhargava P; Brown J; Ames ED; Kang P
Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
[TBL] [Abstract][Full Text] [Related]
9. Typical and atypical bronchopulmonary carcinoid tumors on FDG PET/CT imaging.
Wartski M; Alberini JL; Leroy-Ladurie F; De Montpreville V; Nguyen C; Corone C; Dartevelle P; Pecking AP
Clin Nucl Med; 2004 Nov; 29(11):752-3. PubMed ID: 15483502
[No Abstract] [Full Text] [Related]
10. Bronchial carcinoids with oncocytic features and expressing GLUT1 receptor: does the intense (18)F-FDG uptake correlate with long-term survival?
Leuzzi G; Facciolo F; Treglia G; Lococo F
Hell J Nucl Med; 2014; 17(2):156. PubMed ID: 25097900
[No Abstract] [Full Text] [Related]
11. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
12. Correlation between ¹⁸F-FDG uptake and the expression of glucose transporter-1 and hypoxia-inducible factor-1α in transplanted VX2 tumors.
Xu H; Li B; Yu W; Wang H; Zhao X; Yao Y; Huang D
Nucl Med Commun; 2013 Oct; 34(10):953-8. PubMed ID: 23887273
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of tumor recurrence from radiation-induced pulmonary fibrosis after stereotactic ablative radiotherapy for lung cancer: characterization of 18F-FDG PET/CT findings.
Nakajima N; Sugawara Y; Kataoka M; Hamamoto Y; Ochi T; Sakai S; Takahashi T; Kajihara M; Teramoto N; Yamashita M; Mochizuki T
Ann Nucl Med; 2013 Apr; 27(3):261-70. PubMed ID: 23299492
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of primary pulmonary carcinoid tumors using FDG PET.
Erasmus JJ; McAdams HP; Patz EF; Coleman RE; Ahuja V; Goodman PC
AJR Am J Roentgenol; 1998 May; 170(5):1369-73. PubMed ID: 9574618
[TBL] [Abstract][Full Text] [Related]
15. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid.
Venkitaraman B; Karunanithi S; Kumar A; Khilnani GC; Kumar R
Eur J Nucl Med Mol Imaging; 2014 May; 41(5):856-64. PubMed ID: 24435773
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D
Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007
[TBL] [Abstract][Full Text] [Related]
17. Marked 18-Fuorine-Fluorodeoxyglucose (FDG) Avidity of an Intrapulmonary Typical Carcinoid Tumor Manifesting as a Bronchocele in an Asymptomatic Middle-Aged Woman.
Saadé-Yordán C; McBurney-Henriquez E; González-Santoni R; Gurrea-Rosas C; Montalvo-Fitzpatrick J; Maldonado-Vargas JA
Am J Case Rep; 2017 Dec; 18():1390-1395. PubMed ID: 29282351
[TBL] [Abstract][Full Text] [Related]
18. The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules.
Daniels CE; Lowe VJ; Aubry MC; Allen MS; Jett JR
Chest; 2007 Jan; 131(1):255-60. PubMed ID: 17218584
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcomes in 13 patients with bronchopulmonary carcinoid tumors including one recurrent oncocytic carcinoid tumor.
Ueno T; Maki Y; Sugimoto R; Yamashita M; Nakata K; Sugawara Y; Nishimura R; Teramoto N
Gen Thorac Cardiovasc Surg; 2019 May; 67(5):486-489. PubMed ID: 29971648
[TBL] [Abstract][Full Text] [Related]
20. Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
Himpe U; Deroose CM; Leyn PD; Verbeken E; Vansteenkiste J
J Thorac Oncol; 2009 Jan; 4(1):107-8. PubMed ID: 19096317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]